Page 134 - Genomic Medicine in Emerging Economies

References 123

Gregório, S.P., Mury, F.B., Ojopi, E.B., Sallet, P.C., Moreno, D.H., Yacubian, J., Dias-Neto, E., 2005.
Nogo CAA 3’UTR Insertion polymorphism is not associated with Schizophrenia nor with
bipolar disorder. Schizophr. Res. 75 (1), 5–9. doi: 10.1016/j.schres.2004.11.010.
Guerra, M., Ferri, C.P., Sosa, A.L., Salas, A., Gaona, C., Gonzales, V., Prince, M., 2009. Late-life
depression in Peru, Mexico and Venezuela: the 10/66 population-based study. Br. J. Psychiatry
195 (6), 510–515. doi: 10.1192/bjp.bp.109.064055.
Guimaraes, A.P., Schmitz, M., Polanczyk, G.V., Zeni, C., Genro, J., Roman, T., Hutz, M.H., 2009a.
Further evidence for the association between attention deficit/hyperactivity disorder and the
serotonin receptor 1B gene. J. Neural Transm. (Vienna) 116 (12), 1675–1680. doi: 10.1007/
s00702-009-0305-y.
Guimaraes, A.P., Zeni, C., Polanczyk, G., Genro, J.P., Roman, T., Rohde, L.A., Hutz, M.H., 2009b.
MAOA is associated with methylphenidate improvement of oppositional symptoms in boys
with attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 12 (5), 709–714.
doi: 10.1017/s1461145709000212.
Guimaraes, A.P., Zeni, C., Polanczyk, G.V., Genro, J.P., Roman, T., Rohde, L.A., Hutz, M.H., 2007.
Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential
transmission of the HTR2A 452His allele to affected boys. Am. J Med. Genet. B Neuropsychi-
atr. Genet. 144B (1), 69–73. doi: 10.1002/ajmg.b.30400.
Guio-Vega, G.P., Forero, D.A., 2017. Functional genomics of candidate genes derived from
genome-wide association studies for five common neurological diseases. Int. J. Neurosci. 127
(2), 118–123. doi: 10.3109/00207454.2016.1149172.
Hernandez, H.G., Mahecha, M.F., Mejia, A., Arboleda, H., Forero, D.A., 2014. Global long
interspersed nuclear element 1 DNA methylation in a Colombian sample of patients with
late-onset Alzheimer’s disease. Am. J. Alzheimers Dis. Other Demen. 29 (1), 50–53. doi:
10.1177/1533317513505132.
Hernandez, S., Camarena, B., Gonzalez, L., Caballero, A., Flores, G., Aguilar, A., 2016. A family-
based association study of the HTR1B gene in eating disorders. Rev. Bras. Psiquiatr 38 (3),
239–242. doi: 10.1590/1516-4446-2016-1936.
Hounie, A.G., Cappi, C., Cordeiro, Q., Sampaio, A.S., Moraes, I., Rosario, M.C., Miguel, E.C., 2008.
TNF-alpha polymorphisms are associated with obsessive-compulsive disorder. Neurosci. Lett.
442 (2), 86–90. doi: 10.1016/j.neulet.2008.07.022.
Isordia-Salas, I., Barinagarrementeria-Aldatz, F., Leanos-Miranda, A., Borrayo-Sanchez, G.,
Vela-Ojeda, J., Garcia-Chavez, J., Majluf-Cruz, A., 2010. The C677T polymorphism of the meth-
ylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young
Mexican-Mestizo population. Cerebrovasc. Dis. 29 (5), 454–459. doi: 10.1159/000289349.
Jimenez-Castro, L., Raventos-Vorst, H., Escamilla, M., 2011. Substance use disorder and schizo-
phrenia: prevalence and sociodemographic characteristics in the Latin American population.
Actas Esp Psiquiatr. 39 (2), 123–130.
Junqueira, R., Cordeiro, Q., Meira-Lima, I., Gattaz, W.F., Vallada, H., 2004. Allelic association
analysis of phospholipase A2 genes with schizophrenia. Psychiatr. Genet. 14 (3), 157–160.
Karam, S.M., Barros, A.J., Matijasevich, A., Dos Santos, I.S., Anselmi, L., Barros, F., Black, M.M.,
2016. Intellectual disability in a birth cohort: prevalence, etiology, and determinants at the age
of 4 years. Public Health Genomics 19 (5), 290–297. doi: 10.1159/000448912.
Kisely, S., Alichniewicz, K.K., Black, E.B., Siskind, D., Spurling, G., Toombs, M., 2017. The preva-
lence of depression and anxiety disorders in indigenous people of the Americas: a systematic
review and meta-analysis. J. Psychiatr. Res. 84, 137–152. doi: 10.1016/j.jpsychires.2016.09.032.
Kohlrausch, F.B., Gama, C.S., Lobato, M.I., Belmonte-de-Abreu, P., Callegari-Jacques, S.M.,
Gesteira, A., Hutz, M.H., 2008a. Naturalistic pharmacogenetic study of treatment resis-
tance to typical neuroleptics in European-Brazilian schizophrenics. Pharmacogenet. Genomics
18 (7), 599–609. doi: 10.1097/FPC.0b013e328301a763.